Low overheads are not required in this business. Overheads for...

Low overheads are not required in this business.
Overheads for the year ended June 2007 were $8.4 million. CST has about 40 full time staff and this is about as large as it is going to get.
Major customer groups in the U.S. are Military, Public Health, prisons, health care workers, and immigration this is about 70% of the market ($18 million), the orders for tests are in the thousands and hundreds of thousands.
There is no need for costly advertising and marketing campaigns.
Sales are done on a 30 day terms.
The Royalty payment with CSL expired for Europe and Japan in March 2007 which will flow through as profit.

All is set to go for this Biotechnology company. Do not look for the management to even give a snippet of encouragement to their prospects, they fiercely guard there company being pushed as a market darling.
Cheers